1365 results
Contemporary challenges of TAVI: tailored device selection to the anatomy
13 Sep 2024
Watch the replay of this webinar to capture the challenges of specific aortic anatomies, learn how to tailor the device to the patient and so much more!
How to deal with ilio-femoral tortuosity during TAVI procedure: the buddy wire technique to straighten the pathway
09 Sep 2024
Author
Author
Author
Simplified dual-indeflator approach for bioprosthetic valve fracture
02 Sep 2024
The standard BVF procedure involves multiple quick maneuvers. Simplifying the setup, minimizing operator actions, and shortening rapid pacing could reduce associated risks. Find out how!
Author
Author
Author
Structural cardiac interventions in patients with heart failure
27 Aug 2024
The review aims to address the unmet needs in heart failure (HF) management, particularly in patients where structural heart disease coexists with HF and limits the effectiveness of guideline-directed medical therapy (GDMT).
Reviewer
RHEIA - Transcatheter versus surgical aortic valve replacement in women with severe aortic stenosis
01 Sep 2024
While Chiara De Biase interviews Helene Eltchaninoff about the RHEIA trial results, which she presented at the ESC Congress 2024 in London, Panos Xaplanteris shares his perspective on the trial, offering all the essential information and key takeaways you need for your practice!
Author
Author
Author
POPular PAUSE TAVI - Continuation or interruption of oral anticoagulation during TAVI?
02 Sep 2024
Luis Ortega-Paz provides his take on the POPular PAUSE TAVI trial presented by Dirk Jan van Ginkel at the ESC Congress 2024 in London.
Author
NOTION-3 - Percutaneous coronary intervention in patients undergoing transcatheter aortic valve implantation
01 Sep 2024
Make the most of the insights from Jacob Thomsen Loenborg’s interview with Chiara De Biase and Ali Nazmi Calik’s article to capture the key takeaways from this trial, simultaneously published in the NEJM, presented at the ESC Congress 2024 in London.
Author
Author
Author
PCRonline @ ESC Congress 2024: the interventional cardiology perspective!
26 Jul 2024
What was new and hot in interventional cardiology at #ESCCongress 2024!
TAVI in patients with low surgical risk: an expanding indication?
28 Jun 2024
Discover the risks and benefits of TAVI in patients with low surgical risk, building on the data of the latest randomised trial in this field, the DEDICATE trial, of which Moritz Seiffert was one of the leading investigators.
Controlled ring expansion during aortic valve-in-valve: a proof-of-concept CT-scan analysis
24 Jun 2024
Analyze this EIJ image to see how surgical aortic bioprostheses with expandable ring technology can significantly enhance future ViV procedures.
The LANDMARK RCT: key findings and relevance in clinical practice
15 May 2024 – From EuroPCR 2024
Join Patrick Serruys, Niels Van Royen, and Andreas Baumbach in a roundtable discussing the LANDMARK RCT trial, a randomized comparison of three valves aiming to validate the Myval balloon-expandable THV. Explore the trial's methodology, clinical outcomes, and findings on this new intermediate-size device, which offers adaptability...
New York Valves 2024: Everything you need to know in a nutshell
11 Jun 2024
Alex Sticchi provides his take on the trials which were presented at New York Valves 2024, offering a concise summary, a short description and final thoughts.
Author
First-in-human experience with EasyCross: a novel catheter for a safe and correct aortic valve crossing
14 Jun 2024
This EIJ image highlights a new device designed to enhance the safety and efficiency of ViV TAVI procedures, particularly TAV-in-TAV, by reducing attempts to cross the valve and preventing guidewire misnavigation, thereby minimizing complications and procedure time.
TAVI for today and tomorrow - What matters the most to patients?
28 May 2024
Watch the replay of this webinar with R. Hahn, K. Hayashida, M. Joner and S. Redwood on how to illustrate how TAVI would optimise the full spectrum of lifetime management to all patients and much more!
New evidence on TAVI from PCR Companions
17 May 2024 – From EuroPCR 2024
This session features selected EuroPCR 2024 abstract submissions presenting the latest evidence on TAVI. Topics include device success in valve-in-valve TAVI, next-day discharge after TAVI, comparative network meta-analysis of PCI strategies in TAVI patients, factors associated with thrombosis treatment response, and outcomes of a novel balloon-expandable...
TAVI: how to prevent stroke
17 May 2024 – From EuroPCR 2024
This session focuses on strategies for preventing stroke during TAVI procedures. It features case presentations and discussions on the use of cerebral protection devices, including a novel full-body embolic protection device, and the management of complications such as cerebral hyperperfusion syndrome.
TAVI: procedural complications - Part 1
17 May 2024 – From EuroPCR 2024
This session, comprising selected EuroPCR 2024 Clinical Case submissions, focuses on the management of various procedural complications that can arise during Transcatheter Aortic Valve Implantation (TAVI). Participants will delve into cases involving unexpected outcomes, such as nosecone-related issues, dysphagia and haematemesis, and frozen leaflets in self-expanding...
TAVR in challenging anatomies
17 May 2024 – From EuroPCR 2024
This session focuses on navigating TAVR procedures in complex anatomical scenarios. It covers topics such as optimizing the position of a TAVR valve in a stentless bioprosthesis, managing an unexpected deep position of a TAVR implant, dealing with a completely radiolucent failing surgical bioprosthetic valve, and...
Transcatheter solutions for combined valve disease
17 May 2024 – From EuroPCR 2024
This session delves into the transcatheter management of patients with combined valve disease, including cases of concomitant aortic stenosis and mitral regurgitation, failed bioprostheses in both the aortic and mitral valves, and severe aortic regurgitation after previous valve-sparing root replacement. The session features case presentations and...
Scientific highlights, clinical trial updates and key learnings from EuroPCR 2024
17 May 2024 – From EuroPCR 2024
Davide Capodanno presents notable trial updates, coronary devices, and key takeaways from EuroPCR 2024. Highlights include the SOLVE-TAVI and IDEAL-LM trials at 5 years, BIOADAPTOR at 2 years, advancements in drug-coated balloons and DES, as well as insights from REC-CAGEFREE II, LANDMARK, and NOTION-2.
References
- SOLVE-TAVI: Feistritzer HJ, et al....
